Matt Phillips, President of Cyvex Nutrition, announced that the company is hosting a Vendorworks presentation at SupplySide West in Las Vegas. The seminar will be held on Wednesday, October 22, 2008 from 1:00 p.m. to 1:50 p.m. in Galileo 903.
The seminar, entitled, “Chirositol™: A Breakthrough Ingredient for use in Blood Sugar and Lipid Management,” will be led by Joseph Larner, M.D., Ph.D (Biochemistry), Chairman, Department of Pharmacology, University of Virginia School of Medicine (Ret.), Director of University Diabetes Research and Training Center.
Dr. Larner will discuss how the administration of D-chiro-inositol (DCI) to diabetic humans and animals decreases elevated blood glucose and lipid levels. DCI also acts as an antioxidant reducing reactive oxygen species, improving blood vessel health and maintaining nitric oxide signaling. DCI, when administered in combination with manganese chloride, was found to more effectively reduce elevated plasma glucose in diabetic rats.
“Our Vendorworks presentation is significant in that Dr. Joseph Larner is the discoverer of D-chiro-inositol in relation to insulin resistance and will be reviewing the science behind this unique nutraceutical ingredient,” says Phillips.
Chirositol™ D-chiro-inositol is manufactured exclusively for Cyvex Nutrition, Inc. by Amicogen of South Korea.
Cyvex Nutrition will be at booth 15067 during SupplySide West. Call (949) 622-9030 or log onto www.cyvex.com for more information.